Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

Why Inhaler Device Design and Technique Matters

Facial Rashes Case Studies – Practical Guide to Assessment and Management

Abdominal Pain in Children – Practical Approach in GP

Practical Guide to Improving Control of T2D

expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis